Please login to view this media
- Talk
- 15/09/2021
- Canada
Patients with Hip Fractures Treated with Arthroplasty Demonstrate Prolongued Hypercoagulability and Increased Venous Thromboembolism Risk
Description
This presentation by Daniel You, a PGY-3 at the University of Calgary, addresses the critical issue of hypercoagulability in patients with hip fractures treated with arthroplasty. Beginning with a thank you to the College of Engineers and his research team, Daniel outlines the alarming trends in hip fracture incidence, projecting that by 2050, 6.3 million people annually could suffer such injuries. He highlights the elevated risk of venous thromboembolism (VTE) and its association with hip fractures, which is significant in the surgical field, emphasizing the lack of consensus on thromboprophylaxis guidelines post-surgery.
The talk details the use of Thromboelastography (TEG) as a promising diagnostic tool to assess patients' hypercoagulable states, particularly in relation to the treatments they receive following fractures. Daniel reports findings from a prospective cohort study conducted on over 120 patients aged 50 and above, revealing that hypercoagulability peaks two weeks post-surgery, coinciding with the highest risks for VTE. Notably, patients treated with arthroplasty exhibit greater hypercoagulability.
The conclusion urges for a re-evaluation of current thromboprophylaxis duration, suggesting the necessity of extending monitoring and preventive measures beyond the traditional guidelines currently in place. Daniel's findings advocate for personalized thromboprophylaxis interventions, leveraging TEG to enhance patient safety in orthopedic trauma surgery. He closes with gratitude for the opportunity to present this vital research.